{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:40Z","timestamp":1786982200311,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12029-020-00489-7","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T22:02:15Z","timestamp":1598479335000},"page":"1141-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Portal Vein Thrombosis and Markers of Inflammation in Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"51","author":[{"given":"B.I.","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Donghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"489_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s004320050189","volume":"124","author":"M Pirisi","year":"1998","unstructured":"Pirisi M, Avellini C, Fabris C, Scott C, Bardus P, Soardo G, et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol. 1998;124:397\u2013400.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"489_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12072-009-9157-7","volume":"4","author":"BI Carr","year":"2010","unstructured":"Carr BI, Pancoska P, Branch RA. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study. Hepatol Int. 2010;4(1):396\u2013405.","journal-title":"Hepatol Int"},{"key":"489_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/gut.48.1.103","volume":"48","author":"M Schoniger-Hekele","year":"2001","unstructured":"Schoniger-Hekele M, Muller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut. 2001;48:103\u20139.","journal-title":"Gut"},{"key":"489_CR4","doi-asserted-by":"publisher","first-page":"3120185","DOI":"10.1155\/2018\/3120185","volume":"13","author":"H Akkiz","year":"2018","unstructured":"Akkiz H, Carr BI, Kuran S, Karaogullarindandan U, Uskudar O, Tokmak S, et al. Macroscopic portal vein thrombosis in HCC patients. Canad J Gastroenterol Hepatol. 2018;13:3120185. https:\/\/doi.org\/10.1155\/2018\/3120185.","journal-title":"Canad J Gastroenterol Hepatol"},{"key":"489_CR5","volume-title":"Book. Die krankhaften Geschw\u00fclste","author":"RLK Virchow","year":"1863","unstructured":"Virchow RLK. Book. Die krankhaften Geschw\u00fclste. Berlin: August Hirschwald; 1863."},{"key":"489_CR6","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ijc.23173","volume":"121","author":"SP Hussain","year":"2007","unstructured":"Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121:2373\u201380.","journal-title":"Int J Cancer"},{"key":"489_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell."},{"key":"489_CR8","doi-asserted-by":"publisher","unstructured":"Refolo MG, Messa C, Guerra V, Carr BI, D\u2019Alessandro R. Inflammatory mechanisms of HCC development cancers (Basel). 2020;12(3):641. https:\/\/doi.org\/10.3390\/cancers12030641 Published online 2020 Mar 10. PMCID: PMC7139884.","DOI":"10.3390\/cancers12030641"},{"key":"489_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/07357909609018884","volume":"14","author":"C Fabris","year":"1996","unstructured":"Fabris C, Pirisi M, Soardo G, Toniutto P, Falleti E, Vitulli D, et al. Diagnostic usefulness of acute-phase protein measurement in hepatocellular carcinoma. Cancer Investig. 1996;14:103\u20138.","journal-title":"Cancer Investig"},{"key":"489_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/qjmed\/hcq213","volume":"104","author":"IF Godsland","year":"2011","unstructured":"Godsland IF, North BV, Johnston DG. Simple indices of inflammation as predictors of death from cancer or cardiovascular disease in a prospective cohort after two decades of follow-up. QJM. 2011;104:387\u201394.","journal-title":"QJM."},{"key":"489_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/bjc.1962.6","volume":"16","author":"MA Peyman","year":"1962","unstructured":"Peyman MA. The effect of malignant disease on the erythrocyte sedimentation rate. Br J Cancer. 1962;16:56\u201371.","journal-title":"Br J Cancer"},{"key":"489_CR12","unstructured":"Carr BI, Akkiz H, Guerra V, Donghia R, Yal\u00e7\u0131n K, et al. Erythrocyte sedimentation rate and C-reactive protein are markers for tumor aggressiveness and survival in patients with hepatocellular carcinoma. J Clin Trials. 2020; (in press)."},{"key":"489_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/clinchem\/34.2.352","volume":"34","author":"L Sacchetti","year":"1988","unstructured":"Sacchetti L, Castaldo G, Salvatore F. The gamma-glutamyltransferase isoenzyme pattern in serum as a signal discriminating between hepatobiliary diseases, including neoplasias. Clin Chem. 1988;34:352\u20135.","journal-title":"Clin Chem"},{"key":"489_CR14","first-page":"991","volume":"87","author":"K Xu","year":"1992","unstructured":"Xu K, Meng XY, Wu JW, Shen B, Shi YC, Wei Q. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study. Am J Gastroenterol. 1992;87:991\u20135.","journal-title":"Am J Gastroenterol"},{"key":"489_CR15","first-page":"869","volume":"57","author":"BI Carr","year":"2010","unstructured":"Carr BI, Pancoska P, Branch RA. Significance of increased serum GGTP levels in HCC patients. Hepatogastroenterology. 2010;57:869\u201374.","journal-title":"Hepatogastroenterology."},{"issue":"49","key":"489_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002133","volume":"94","author":"MX Li","year":"2015","unstructured":"Li MX, Bi XY, Li ZY, Huang Z, Han Y, Zhou JG, et al. Prognostic role of Glasgow prognostic score in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Medicine. 2015;94(49):e2133.","journal-title":"Medicine."},{"key":"489_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3892\/ol.2017.6104","volume":"14","author":"H Shiba","year":"2017","unstructured":"Shiba H, Horiuchi T, Sakamoto T, Furukawa K, Shirai Y, Iida T, et al. Glasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinoma. Oncol Lett. 2017;14:293\u20138.","journal-title":"Oncol Lett"},{"key":"489_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1159\/000485396","volume":"44","author":"J Zheng","year":"2017","unstructured":"Zheng J, Cai J, Li H, Zeng K, He L, Fu H, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic review. Cell Physiol Biochem. 2017;44:967\u201381.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"489_CR19","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3390\/cancers12051300","volume":"12","author":"JI Yu","year":"2020","unstructured":"Yu JI, Park HC, Yoo GS, Paik SW, Choi MS, Kim HS, et al. Clinical significance of systemic inflammation markers in newly diagnosed, previously untreated hepatocellular carcinoma. Cancers (Basel). 2020;12(5):1300. https:\/\/doi.org\/10.3390\/cancers12051300.","journal-title":"Cancers (Basel)"},{"key":"489_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00004836-199203000-00021","volume":"14","author":"CR Taylor","year":"1992","unstructured":"Taylor CR. Computed tomography in the evaluation of the portal venous system. J Clin Gastroenterol. 1992;14:167\u201372.","journal-title":"J Clin Gastroenterol"},{"key":"489_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2214\/ajr.168.3.9057522","volume":"168","author":"ME Tublin","year":"1997","unstructured":"Tublin ME, Dodd GD 3rd, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol. 1997;168:719\u201323.","journal-title":"AJR Am J Roentgenol"},{"key":"489_CR22","doi-asserted-by":"publisher","first-page":"e13593","DOI":"10.1111\/ijcp.13593","volume":"24","author":"H Akkiz","year":"2020","unstructured":"Akkiz H, Carr BI, Bag HG, Karao\u011fullar\u0131ndan U, Yal\u00e7\u0131n K, Ekin N, et al. Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma. Int J Clin Pract. 2020;24:e13593. https:\/\/doi.org\/10.1111\/ijcp.13593.","journal-title":"Int J Clin Pract"},{"key":"489_CR23","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/bjc.2012.92","volume":"106","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer. 2012;106:1439\u201345.","journal-title":"Br J Cancer"},{"issue":"Spec Issue","key":"489_CR24","first-page":"625","volume":"15","author":"BI Carr","year":"2018","unstructured":"Carr BI, Akkiz H, Guerra V, \u00dcsk\u00fcdar O, Kuran S, et al. C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors. Clin Pract (Lond). 2018;15(Spec Issue):625\u201334.","journal-title":"Clin Pract (Lond)"},{"key":"489_CR25","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s13277-014-2833-9","volume":"36","author":"X Li","year":"2015","unstructured":"Li X, Chen ZH, Xing YF, Wang TT, Wu DH, Wen JY, et al. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumour Biol. 2015;36:2263\u20139.","journal-title":"Tumour Biol"},{"key":"489_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1477-7819-11-92","volume":"11","author":"JM Kim","year":"2013","unstructured":"Kim JM, Kwon CH, Joh JW, Ko JS, Park JB, Lee J, et al. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion. World J Surg Oncol. 2013;11:92.","journal-title":"World J Surg Oncol"},{"key":"489_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10620-015-3922-3","volume":"61","author":"BI Carr","year":"2016","unstructured":"Carr BI, Guerra V. Low alpha-fetoprotein levels are associated with improved survival in hepatocellular carcinoma patients with portal vein thrombosis. Dig Dis Sci. 2016;61:937\u201347.","journal-title":"Dig Dis Sci"},{"key":"489_CR28","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s00535-006-1950-7","volume":"41","author":"S Hagiwara","year":"2006","unstructured":"Hagiwara S, Kudo M, Kawasaki T, Nagashima M, Minami Y, Chung H, et al. Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol. 2006;41:1214\u20139.","journal-title":"J Gastroenterol"},{"key":"489_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","volume":"91","author":"Y Koike","year":"2001","unstructured":"Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer. 2001;91:561\u20139.","journal-title":"Cancer"},{"key":"489_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/jjco\/hyg096","volume":"33","author":"M Gotoh","year":"2003","unstructured":"Gotoh M, Nakatani T, Masuda T, Mizukuchi Y, Sakamoto M, et al. Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin. Jpn J Cl Oncol. 2003;33:522\u20136.","journal-title":"Jpn J Cl Oncol"},{"key":"489_CR31","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/1097-0142(19950415)75:8<2057::AID-CNCR2820750805>3.0.CO;2-K","volume":"75","author":"D Dusenbery","year":"1995","unstructured":"Dusenbery D, Dodd GD 3rd, Carr BI. Percutaneous fine-needle aspiration of portal vein thrombi as a staging technique for hepatocellular carcinoma. cytologic findings of 46 patients. Cancer. 1995;75:2057\u201362.","journal-title":"Cancer."},{"key":"489_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2214\/ajr.161.2.8392785","volume":"161","author":"GD Dodd 3rd","year":"1993","unstructured":"Dodd GD 3rd, Carr BI. Percutaneous biopsy of portal vein thrombus: a new staging technique for hepatocellular carcinoma. Am J Roentgenol. 1993;161:229\u201333.","journal-title":"Am J Roentgenol"},{"key":"489_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/B978-0-12-420117-0.00003-7","volume":"122","author":"M Hanigan","year":"2014","unstructured":"Hanigan M. Gamma-glutamyl transpeptidase: redox regulation and drug resistance. Adv Cancer Res. 2014;122:103\u201341.","journal-title":"Adv Cancer Res"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00489-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00489-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00489-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T19:40:11Z","timestamp":1630006811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00489-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00489-7","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"27 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This work complies with the guidelines of the World Medical Association, Declaration of Helsinki. This work was approved by each institution\u2019s IRB as documented in the \u201c\n                      \n                      \u201d section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Ethics"}}]}}